Camlin Fine Sciences Completes Vinpai Tender Offer

Transaction Details

Camlin Fine Sciences Limited (CFSL) has successfully completed its simplified cash tender offer (offre publique d'achat simplifiée or OPAS) for the remaining shares of Vinpai (ISIN: FR001400AXT1; mnémonique: ALVIN) on Euronext Growth Paris. The tender offer period closed on July 6, 2026.

Ownership Statistics

Following the completion of the OPAS:

• CFSL holds 4,351,894 Vinpai shares (including 26,736 treasury shares treated as held by CFSL under French commercial code article L. 233-9, I, 2°)
• CFSL holds 4,325,158 theoretical voting rights in Vinpai
• This represents 95.41% of Vinpai's share capital
• This represents 91.46% of theoretical voting rights (based on total of 4,728,855 theoretical voting rights according to AMF general regulation article 223-11, al 2)

Key Decision

CFSL confirmed it will not request the French financial markets authority (Autorité des marchés financiers or AMF) to implement a squeeze-out procedure for the remaining Vinpai shares from Euronext Growth Paris. This decision was previously communicated in CFSL's press release dated March 16, 2026.

Legal Restrictions

The press release contains extensive legal disclaimers restricting distribution in the United States of America, Australia, Canada, South Africa, Japan, and other jurisdictions where local restrictions may apply. The offering was not registered under the U.S. Securities Act of 1933.

Advisors

CFSL was advised by Fontaine Avocats as legal advisor for the transaction.